Cal-Maine Foods
CALM Nasdaq Packaged Foods & Meats Financials FY2017βFY2026
Cal-Maine Foods' revenue fell 31.7% to $2.9 billion in fiscal 2026. Its operating margin was 12.0%, down from 36.0% a year earlier. Free cash flow was $329 million, down 69.1%. It paid out $232 million in dividends and buybacks, 70% of free cash flow. The diluted share count fell 2.3%.
About these figures. Interest coverage for fiscal 2026 is blank: the 10-K's structured data has no interest expense for that year.
What Cal-Maine Foods does
No business description yet.
- Legal name
- CAL-MAINE FOODS, INC.
- Fiscal year ends
- May 30, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001562762-26-000080
0000016160
Revenue and margins
Cal-Maine Foods had $2.9B of revenue in fiscal 2026, down 31.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $329M in fiscal 2026, 11.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cal-Maine Foods returned $232M to shareholders in fiscal 2026, 71% of free cash flow. The diluted share count fell 2.3%.
Value Cal-Maine Foods yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 47.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 51.3x Β· peers 27.4x Β· sector 24.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Cal-Maine Foods can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $175M | $648M | $812M | $1.4B | $924M |
| Interest coverage | 356.2x | 1,659.9x | 569.1x | 2,510.7x | β |
| Current ratio | 3.6x | 6.2x | 5.5x | 6.4x | 7.7x |
| Quick ratio | 2.2x | 4.6x | 4.3x | 5.4x | 5.9x |
| Total assets | $1.4B | $2.0B | $2.2B | $3.1B | $3.1B |
| Total liabilities | $323M | $345M | $388M | $519M | $467M |
| Shareholders' equity | $1.1B | $1.6B | $1.8B | $2.6B | $2.6B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β8.4% | β0.2% | β5.3% |
| Altman Z'' | 11.49 | 14.78 | 12.50 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Cal-Maine Foods CALM | $2.9B | β31.7% | 12.0% | 11.3% | β | 51.3x | β | |
| Del Monte DMC | $1.4B | 1.0% | 3.2% | 4.2% | 4.5% | 42.2x | 7 | Compare β |
| Marzetti MZTI | $3.0B | 1.1% | 12.4% | 10.7% | 18.2% | 15.6x | 6 | Compare β |
| Flowers Foods FLO | $1.3B | 3.0% | 3.3% | 6.1% | 4.6% | 22.8x | 5 | Compare β |
| J&J Snack Foods JJSF | $1.6B | 0.5% | 5.3% | 5.2% | 7.3% | 32.1x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.5B | $1.4B | $1.4B | $1.3B | $1.8B | $3.1B | $2.3B | $4.3B | $2.9B |
| Gross profit | $45.5M | $361M | $223M | $180M | $161M | $337M | $1.2B | $542M | $1.9B | $672M |
| Operating income | β$134M | $101M | $45.8M | $1.3M | β$26.3M | $144M | $968M | $313M | $1.5B | $350M |
| Interest expense | $0.3M | $0.3M | $0.6M | $0.5M | $0.2M | $0.4M | $0.6M | $0.5M | $0.6M | β |
| Pretax income | β$114M | $117M | $70.8M | $20.1M | β$9.9M | $166M | $999M | $360M | $1.6B | $411M |
| Income tax | β$39.9M | β$8.9M | $15.7M | $1.7M | β$12.0M | $33.6M | $242M | $83.7M | $385M | $92.9M |
| Net income | β$74.3M | $126M | $54.2M | $18.4M | $2.1M | $133M | $758M | $278M | $1.2B | $317M |
| Diluted EPS | β$1.54 | $2.60 | $1.12 | $0.38 | $0.04 | $2.72 | $15.52 | $5.69 | $24.95 | $6.63 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | β$45.9M | $200M | $115M | $73.6M | $26.1M | $126M | $863M | $451M | $1.2B | $480M |
| Capital expenditure | $66.7M | $19.7M | $68.0M | $124M | $95.1M | $72.4M | $137M | $147M | $161M | $151M |
| Free cash flow | β$113M | $181M | $47.1M | β$50.6M | β$68.9M | $53.8M | $726M | $304M | $1.1B | $329M |
| Depreciation and amortization | $49.1M | $54.0M | $54.6M | $58.1M | $59.5M | $68.4M | $72.2M | $80.2M | $94.0M | $124M |
| Stock-based compensation | $3.4M | $3.5M | $3.6M | $3.6M | $3.8M | $4.1M | $4.2M | $4.4M | $4.5M | $5.8M |
| Acquisitions | $85.8M | $0.0M | $17.9M | $44.6M | $0.0M | $44.8M | $0.0M | $53.7M | $116M | $428M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $0.0M | $0.0M | $41.7M | $0.0M | $1.7M | $6.1M | $252M | $91.9M | $330M | $232M |
| Dividends and buybacks | $0.0M | $0.0M | $41.7M | $0.0M | $1.7M | $6.1M | $252M | $91.9M | $330M | $232M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $17.6M | $48.4M | $69.2M | $232M | $170M | $175M | $648M | $812M | $1.4B | $924M |
| Total debt | $10.9M | $6.1M | $2.3M | β | β | β | β | β | β | β |
| Finance lease liabilities | $0.0M | $0.0M | $1.1M | $0.9M | $0.7M | $0.4M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $436M | $588M | $568M | $522M | $520M | $662M | $1.1B | $1.2B | $2.0B | $1.6B |
| Current liabilities | $64.7M | $108M | $74.9M | $93.2M | $90.1M | $185M | $183M | $228M | $308M | $206M |
| Inventory | $161M | $169M | $172M | $187M | $218M | $263M | $284M | $262M | $296M | $375M |
| Property and equipment, net | $458M | $425M | $455M | $557M | $589M | $678M | $745M | $857M | $1.0B | $1.3B |
| Total assets | $1.0B | $1.2B | $1.2B | $1.2B | $1.2B | $1.4B | $2.0B | $2.2B | $3.1B | $3.1B |
| Total liabilities | $189M | $195M | $167M | $197M | $216M | $323M | $345M | $388M | $519M | $467M |
| Shareholders' equity | $843M | $953M | $987M | $1.0B | $1.0B | $1.1B | $1.6B | $1.8B | $2.6B | $2.6B |
| Margins | ||||||||||
| Gross margin | 4.2% | 24.0% | 16.4% | 13.3% | 11.9% | 19.0% | 38.0% | 23.3% | 43.4% | 23.1% |
| Operating margin | β12.5% | 6.7% | 3.4% | 0.1% | β2.0% | 8.1% | 30.8% | 13.4% | 36.1% | 12.0% |
| EBITDA margin | β7.9% | 10.3% | 7.4% | 4.4% | 2.5% | 11.9% | 33.1% | 16.9% | 38.3% | 16.3% |
| Net margin | β6.9% | 8.4% | 4.0% | 1.4% | 0.2% | 7.5% | 24.1% | 11.9% | 28.6% | 10.9% |
| FCF margin | β10.5% | 12.0% | 3.5% | β3.7% | β5.1% | 3.0% | 23.1% | 13.1% | 25.0% | 11.3% |
| Returns | ||||||||||
| Return on capital | β12.1% | 11.5% | 3.9% | β | β | β | β | β | β | β |
| Return on capital employed | β13.4% | 10.0% | 4.3% | 0.1% | β2.3% | 12.1% | 64.2% | 16.8% | 64.9% | 12.3% |
| Return on equity | β8.5% | 14.0% | 5.6% | 1.8% | 0.2% | 12.5% | 55.8% | 16.3% | 56.0% | 12.2% |
| Return on assets | β6.9% | 11.5% | 4.7% | 1.6% | 0.2% | 10.0% | 44.8% | 13.4% | 46.3% | 10.2% |
| Growth | ||||||||||
| Revenue growth | β43.7% | 39.9% | β9.4% | β0.7% | β0.2% | 31.7% | 77.0% | β26.1% | 83.2% | β31.7% |
| Net income growth | β123.5% | β | β56.9% | β66.1% | β88.8% | 6,339.3% | 471.5% | β63.3% | 339.0% | β74.0% |
| EPS growth | β123.6% | β | β56.9% | β66.1% | β89.5% | 6,700.0% | 470.6% | β63.3% | 338.5% | β73.4% |
| FCF growth | β136.1% | β | β73.9% | β207.4% | β | β | 1,250.0% | β58.1% | 249.5% | β69.1% |
| Share count change | β0.0% | 0.2% | 0.3% | β0.0% | 0.2% | 0.2% | 0.2% | 0.1% | 0.0% | β2.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β0.3x | β0.7x | β | β | β | β | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | β | β | β | β | β | β | β |
| Interest coverage | β421.8x | 379.3x | 71.1x | 2.6x | β123.3x | 356.2x | 1,659.9x | 569.1x | 2,510.7x | β |
| Current ratio | 6.7x | 5.5x | 7.6x | 5.6x | 5.8x | 3.6x | 6.2x | 5.5x | 6.4x | 7.7x |
| Quick ratio | 4.3x | 3.9x | 5.3x | 3.6x | 3.4x | 2.2x | 4.6x | 4.3x | 5.4x | 5.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.2% | 1.3% | 5.0% | 9.2% | 7.1% | 4.1% | 4.3% | 6.3% | 3.8% | 5.2% |
| Stock comp / revenue | 0.3% | 0.2% | 0.3% | 0.3% | 0.3% | 0.2% | 0.1% | 0.2% | 0.1% | 0.2% |
| Payouts / FCF | β | 0.0% | 88.6% | β | β | 11.4% | 34.7% | 30.2% | 31.1% | 70.5% |
| Quality scores | ||||||||||
| Piotroski F-score | 3.0 | 7.0 | 5.0 | β | β | β | β | β | β | β |
| Altman Z'' | 8.8 | 11.1 | 12.0 | 10.4 | 9.7 | 8.9 | 14.0 | 11.5 | 14.8 | 12.5 |
| Accruals ratio | β2.6% | β6.8% | β5.3% | β4.7% | β2.0% | 0.5% | β6.2% | β8.4% | β0.2% | β5.3% |
Source: SEC EDGAR XBRL filings (CIK 0000016160). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.